Mosaic Clinical Technologies’ Cognita AI Model Earns FDA Breakthrough Device Designation
Mosaic Clinical Technologies has received FDA Breakthrough Device Designation for Cognita CXR, a generative AI model designed to assist radiologists in interpreting chest X-rays. The designation allows prioritized interaction with the agency as the company advances toward clearance.